Prenetics

Prenetics Global Limited, trading under the NASDAQ symbol PRE, is a health sciences company incorporated in the Cayman Islands with headquarters in the USA and Hong Kong. Since its establishment in 2014, Prenetics has concentrated on advancing both consumer and clinical health through innovative genetic testing and early disease detection solutions. Its consumer efforts are spearheaded by the health and wellness brand IM8, while its clinical division is represented by Insighta, a venture focused on multi-cancer early detection technologies. Additionally, Prenetics provides extensive DNA testing services via CircleDNA, which utilizes next-generation sequencing technology to offer insights into health, wellness, and genetic predispositions.

A significant aspect of Prenetics' strategy is its integration of genomics with blockchain technology, as evidenced by its partnership with Humanity Protocol, a decentralized identity verification company. This collaboration incorporates Prenetics' CircleDNA service into Humanity Protocol's infrastructure, facilitating the issuance of blockchain-based Proof of Personhood credentials. This initiative highlights Prenetics’ commitment to enhancing secure identity verification by merging genomic data with blockchain technology.

Prenetics also demonstrates a strategic approach to digital assets, including Bitcoin, as part of its business model. The company's investment in digital assets aligns with its broader strategy to integrate blockchain technology within its operations. This forward-thinking approach positions Prenetics at the intersection of health sciences and digital innovation, reflecting its proactive stance in incorporating emerging technologies to strengthen its market position and offer advanced solutions in health science.